Garuda Therapeutics Stock

garudatx.comHealthcare / BioTech & PharmaFounded: 2021

Garuda Therapeutics offers platform technology that aids in the development of off-the-shelf hematopoietic stem cell (HSC) therapies that treat a range of severe and life-threatening diseases. The goal of the company is to make it easier for patients to access stem-cell therapies by providing consistent, durable, and HLA-compatible treatments for a broad range of diseases. Garuda Therapeutics was founded in the Boston, Massachusetts area in 2021.

Register To Buy and Sell Shares

For more details on financing and valuation for Garuda Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Garuda Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Garuda Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Frequently Asked Questions About Garuda Therapeutics’ Stock

Can you buy Garuda Therapeutics’ stock?
Garuda Therapeutics is not publicly traded on NYSE or NASDAQ in the U.S. To buy Garuda Therapeutics’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Garuda Therapeutics’ stock?
Yes, you can sell stock of a private company like Garuda Therapeutics. Forge can help you sell your Garuda Therapeutics stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Garuda Therapeutics’ stock price?
Garuda Therapeutics is a privately held company and therefore does not have a public stock price. However, you may access Garuda Therapeutics’ private market stock price with Forge Data.
What is Garuda Therapeutics’ stock ticker symbol?
Garuda Therapeutics does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Garuda Therapeutics Secures $62 Million Series B Financing to Advance Off-the-Shelf Blood Stem Cell Technology Platform
Garuda Therapeutics (Garuda), a company creating off-the-shelf, durable blood stem cell-based cellular therapies, today announced a $62 million Series B financing led by Northpond Ventures, OrbiMed Advisors, Cormorant Asset Management, and Aisling Capital.
Updated on: Apr 20, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.